MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

10.69 +0.05 (+0.47%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. 
Via Benzinga
News headline image
Why Viatris Stock Is Jumping Today ↗
Investors are applauding a key step in Viatris' plans to return to growth. 
Via The Motley Fool
News headline image
Oyster Point Pharma (NASDAQ: OYST) Enters Into Agreement to be Acquired by Viatris (NASDAQ: VTRS) For $11 Per Share Plus CVR Up to $2.00 Per Share
Oyster Point Pharma, Inc. (NASDAQ: OYST) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development 
Via Spotlight Growth
News headline image
Why Viatris Shares Are Soaring Higher ↗
Viatris Inc (NASDAQ: VTRS) shares are trading higher by 16.80% to $11.33 Monday morning after the company announced it will acquire Oyster Point Pharma. What Happened? 
Via Benzinga
News headline image
Viatris' Mylan Recalls One Lot Of Octreotide Acetate Injection Due To Glass Particulates ↗
 
Via Benzinga
News headline image
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge ↗
 
Via Benzinga
News headline image
IAA Stock Moves as Ritchie Bros Acquires Company in $7.3 Billion Deal ↗
IAA (IAA) stock is moving on Monday thanks to a massive acquisition $7.3 billion deal with Ritchie Bros Auctioneers (RBA). 
Via InvestorPlace
News headline image
Viatris (VTRS) Stock Pops 17% on Acquisition News ↗
One press release with numerous positive catalysts is prompting some VTRS stock traders to load up on the shares today. 
Via InvestorPlace
News headline image
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market? ↗
The generic drug market has been growing since 1984 when the Hatch-Waxman Act encouraged manufacturing generics and developed a framework to regulate them. 
Via Benzinga
News headline image
Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Cano Health Inc (NYSE: CANO). 
Via Benzinga
News headline image
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
From Oyster Point Pharma, Inc.
Via GlobeNewswire
News headline image
Recap: Viatris Q3 Earnings ↗
Viatris (NASDAQ:VTRS) reported its Q3 earnings results on Monday, November 7, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Earnings Viatris beat estimated earnings by... 
Via Benzinga
News headline image
How To Attend Viatris Q3 2022 Earnings Conference Call ↗
Viatris (NASDAQ:VTRS) will host a conference call at 08:30 AM ET on November 7, 2022, to discuss Q3 2022 earnings results. How to Attend Viatris (VTRS) Conference Call Follow this link to access the... 
Via Benzinga
News headline image
3 Feel-Good Ways to Lose Lots of Money in the Bear Market ↗
All three are liable to happen when you lose your focus on investing for the long term. 
Via The Motley Fool
News headline image
Recent Stock Purchase Update For October 2022 ↗
As you may know by now, I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines. Let's take a look at what I've added to my portfolio... 
Via Talk Markets
News headline image
Earnings Scheduled For November 7, 2022 ↗
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. 
Via Benzinga
News headline image
3 Healthcare Stocks That Are Too Cheap to Ignore ↗
They all offer attractive dividends, too. 
Via The Motley Fool
News headline image
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later ↗
Procrastination could be problematic with these three bargain stocks. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Novartis Fails To Prevent Generic Competition For Its Blockbuster Multiple Sclerosis Drug ↗
The U.S. Supreme Court rejected Novartis AG's (NYSE: NVS) effort to block the launch of generic versions of its multiple sclerosis drug Gilenya. 
Via Benzinga
News headline image
US Supreme Court Turns Away Biogen's Last Effort To Reinstate Tecfidera Patent ↗
The U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen Inc's (NASDAQ: BIIB) blockbuster drug Tecfidera. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 1076 companies hit new 52-week lows. 
Via Benzinga
News headline image
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs ↗
The decision affects two of Merck's best-selling drugs. 
Via Investor's Business Daily
News headline image
Recent Stock Purchase September 2022 ↗
I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines. 
Via Talk Markets
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 507 stocks hit new 52-week lows. 
Via Benzinga
News headline image
7 Screaming Buy Stock Picks to Beat the September Market Slump ↗
Savvy investors can use these stock picks to beat the market and take advantage of market weakness and panic selling. 
Via InvestorPlace
News headline image
September 2022 Stock Considerations ↗
Let’s take a look at my September stock considerations which are similar to recent considerations from one to four months ago. 
Via Talk Markets
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 429 stocks made new 52-week lows. 
Via Benzinga
News headline image
Is Viatris Inc. a Contrarian Dividend Option for Your Portfolio?
Does kicking against market trends make you even more excited about investing? If so, you may want to consider drugmaker Viatris Inc. (NASDAQ: VTRS), which produces products that treat diabetes,... 
Via MarketBeat
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 529 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story